Literature DB >> 12548528

Individual attributes versus composite scores of nerve conduction abnormality: sensitivity, reproducibility, and concordance with impairment.

Peter J Dyck1, William J Litchy, Jasper R Daube, C Michel Harper, P James B Dyck, Jenny Davies, Peter C O'Brien.   

Abstract

Composite scores may be more sensitive and reproducible than single attributes of nerve conduction for detection of peripheral neuropathy, but this requires validation in large patient cohorts. Also, the concordance of individual attributes versus composite scores with clinical measures of severity has not been tested. Here, we study these issues in prospectively studied cohorts: diabetic patients from Rochester, Minnesota (RDNS; n = 396); chronic inflammatory demyelinating polyneuropathy (CIDP) patients (n = 55); and multifocal motor neuropathy (MMN) patients (n = 18). With specificity fixed at the 97.5 percentile, we found that, in generalized polyneuropathies (diabetic and CIDP), composite scores (especially ones including conduction velocity, distal latencies, and F-waves) of individual or multiple nerves tended to be more sensitive than individual attributes. By contrast, for multiple mononeuropathies, some individual attributes or composite scores of individual nerves were more sensitive than composite scores. In diabetic polyneuropathy, composite scores tended to be more reproducible than individual attributes of nerve conduction. Highly significant correlations were found between individual attributes or composite scores and neurologic impairment in diabetic polyneuropathy and in CIDP; in general, correlation coefficients were higher for composite scores. These correlations were higher for amplitudes than for conduction velocities or distal latencies. We conclude that, with the availability of microprocessors and normative databases, electromyographers may increasingly seek to express nerve conduction abnormality also as composite scores of individual or several nerves.

Entities:  

Mesh:

Year:  2003        PMID: 12548528     DOI: 10.1002/mus.10320

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  21 in total

1.  Polyneuropathy dysfunction scores.

Authors:  P J Dyck; P C O'Brien
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-05-18       Impact factor: 10.154

Review 2.  Mobility-Related Consequences of Reduced Lower-Extremity Peripheral Nerve Function with Age: A Systematic Review.

Authors:  Rachel E Ward; Paolo Caserotti; Jane A Cauley; Robert M Boudreau; Bret H Goodpaster; Aaron I Vinik; Anne B Newman; Elsa S Strotmeyer
Journal:  Aging Dis       Date:  2015-11-27       Impact factor: 6.745

3.  Reproducibility of peroneal motor nerve conduction measurement in older adults.

Authors:  Rachel E Ward; Robert M Boudreau; Aaron I Vinik; Sasa A Zivkovic; Omer T Njajou; Suzanne Satterfield; Tamara B Harris; Anne B Newman; Elsa S Strotmeyer
Journal:  Clin Neurophysiol       Date:  2012-09-26       Impact factor: 3.708

4.  Signs and symptoms versus nerve conduction studies to diagnose diabetic sensorimotor polyneuropathy: Cl vs. NPhys trial.

Authors:  Peter J Dyck; Carol J Overland; Phillip A Low; William J Litchy; Jenny L Davies; P James B Dyck; Peter C O'Brien; James W Albers; Henning Andersen; Charles F Bolton; John D England; Christopher J Klein; J Gareth Llewelyn; Michelle L Mauermann; James W Russell; Wolfgang Singer; A Gordon Smith; Solomon Tesfaye; Adrian Vella
Journal:  Muscle Nerve       Date:  2010-08       Impact factor: 3.217

5.  Serum albumin is associated with peripheral nerve function in patients with type 2 diabetes.

Authors:  Lu Li; Bo Liu; Jingyi Lu; Lan Jiang; Yinan Zhang; Yingdi Shen; Congrong Wang; Weiping Jia
Journal:  Endocrine       Date:  2015-04-10       Impact factor: 3.633

6.  Heat shock protein 27 is associated with better nerve function and fewer signs of neuropathy.

Authors:  K Pourhamidi; L B Dahlin; K Boman; O Rolandsson
Journal:  Diabetologia       Date:  2011-09-10       Impact factor: 10.122

7.  Tafamidis for transthyretin familial amyloid polyneuropathy: a randomized, controlled trial.

Authors:  Teresa Coelho; Luis F Maia; Ana Martins da Silva; Marcia Waddington Cruz; Violaine Planté-Bordeneuve; Pierre Lozeron; Ole B Suhr; Josep M Campistol; Isabel Maria Conceição; Hartmut H-J Schmidt; Pedro Trigo; Jeffery W Kelly; Richard Labaudinière; Jason Chan; Jeff Packman; Amy Wilson; Donna R Grogan
Journal:  Neurology       Date:  2012-07-25       Impact factor: 9.910

8.  Painful diabetic neuropathy is associated with greater autonomic dysfunction than painless diabetic neuropathy.

Authors:  Rajiv A Gandhi; Jefferson L B Marques; Dinesh Selvarajah; Celia J Emery; Solomon Tesfaye
Journal:  Diabetes Care       Date:  2010-07       Impact factor: 19.112

9.  Diabetic neuropathy: a cross-sectional study of the relationships among tests of neurophysiology.

Authors:  Christopher H Gibbons; Roy Freeman; Aristidis Veves
Journal:  Diabetes Care       Date:  2010-08-30       Impact factor: 19.112

10.  Neurophysiological testing correlates with clinical examination according to fibre type involvement and severity in sensory neuropathy.

Authors:  J-P Lefaucheur; A Créange
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-03       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.